article thumbnail

How using AI in clinical trials accelerates drug development

Pharmaceutical Technology

Drug development is already a difficult endeavor, with the vast majority of R&D efforts failing to produce a market-worthy product. Even reaching the clinical trial phase offers no guarantees, as only 12% of such drugs receive U.S. While this process is essential, it’s also slow, expensive and unpredictable.

article thumbnail

How blockchain can revolutionise medical records and save lives

pharmaphorum

Many practitioners have expressed the feeling that EHRs cause far too much of their time ultimately being spent on data entry. Phones and similar devices now have the power and communication abilities to monitor an individual’s vitals and be an access point for both inputting and retrieving data.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Data integrity considerations in Pharma and Life Sciences

European Pharmaceutical Review

Data integrity is the term used to describe the accuracy, consistency and reliability of data throughout its lifecycle. In the pharmaceutical/life sciences industries, maintaining data integrity is crucial given its role in making critical decisions that shape outcomes from drug development to human health.

article thumbnail

How a new investment is powering a revolution in clinical trial operations

pharmaphorum

Clinical trials are the engine for pharmaceutical innovation, but their means of capturing and communicating data are stuck in the past. While many pieces of the drug development process have digitised to keep pace with the speed of technological advancements, clinical trials continue to lag amidst pharma’s digital transformation.